GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes.

Ditchfield C, Macleod M, Price JMJ, Davis ET, Jones SW

Open source

DOI
10.1007/s11357-026-02625-w
Published
2026 Nov 4
Container
GeroScience
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11357-026-02625-w,
  title = {GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes.},
  author = {Ditchfield C and Macleod M and Price JMJ and Davis ET and Jones SW},
  year = {2026},
  journal = {GeroScience},
  doi = {10.1007/s11357-026-02625-w},
  url = {https://doi.org/10.1007/s11357-026-02625-w}
}

RIS

TY  - JOUR
TI  - GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes.
AU  - Ditchfield C
AU  - Macleod M
AU  - Price JMJ
AU  - Davis ET
AU  - Jones SW
PY  - 2026
JO  - GeroScience
DO  - 10.1007/s11357-026-02625-w
UR  - https://doi.org/10.1007/s11357-026-02625-w
ER  - 

APA

C, D., M, M., JMJ, P., ET, D., & SW, J. (2026). GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes.. GeroScience. https://doi.org/10.1007/s11357-026-02625-w

Source records